Blog

Home  >  Resources  >  Blog

RJ Health Systems was on the road over the last month attending AMCP and Asembia (formerly Armada) conferences, gaining insight into industry trends and interacting with our customers face to face. AMCP: At this year’s Academy of Managed Care Pharmacy (AMCP) Meeting in San Francisco from April 20th to 22nd, more than 4,200 managed care […]

RJ Health Systems’ most recent April 27th Specialty Pharmacy Webinar “Utilizing NDCs for Medical Benefit Drugs – A Payor’s Perspective” focused on improving drug data capture on Medical Drug Claims. The webinar described the limitations of the HCPCS model and the value of alternatively using the FDA assigned NDC for drug billing purposes. The webinar […]

The FDA have just approved a Remicade biosimilar on Tuesday, April 5th. It will go by the name “Inflectra.” Inflectra becomes the second biosimilar drug to be approved by the FDA for the U.S. market. The drug was developed by Celltrion and will be co-marketed by Pfizer. It is a form of infliximab, but will […]

RJ Health Systems recently attended the 21st annual PBMI (Pharmacy Benefit Management Institute) drug conference and had the opportunity to present insights on leveraging ReimbursementCodes to control Specialty Drug Spend. We were able to learn from industry experts and thought leaders on diverse topics on best managing the pharmacy benefit. Our own Randy Falkenrath, Customer […]

ReimbursementCodes is now your single-source for identifying up-to-date information regarding NDCs that are included on the CMS Medicaid Rebate List. The newest offering from RJ Health Systems enhances ReimbursementCodes with information indicating which NDCs qualify for Medicaid rebate. Our Rebate Optimization Tool can help you navigate the confusing NDC landscape and simplify the process of […]

RJ Health Systems is hitting the road this spring! Our team will be attending and speaking at several conferences to share RJ’s breadth of products and services with Payors, PBMs, Specialty Pharmacies, Infusion Companies, Medicaid Organizations, Physicians and Medical Billing companies. We want to engage with our customers and discuss how you are using our […]

There is escalating concern at the FDA for an increasing number of Biosimilar applications in the coming year. Janet Woodcock, director of FDA’s Center for Drug Evaluation and Research, told members of the U.S. House Energy and Commerce Committee’s health subcommittee she is concerned about the agency’s ability to manage what she expects will be […]

To Our Valued Customers: 2015 was an unbelievable year of growth for RJ Health, and we cannot thank you and your organization enough for being a part of our journey. We spent the year side-by-side with many of you in order to capture your “voice” and define our product roadmap. Here are five trends we […]

What: Specialty Drug Webinar on Biosimilars When: February 17, 2016 from 2 – 3 PM (EST) Click Here to REGISTER NOW  – Seats are Limited! Join RJ Health Systems for the final in a series of two webinars focusing on Biosimilars and what effect they will have on the Specialty Drug Industry. “Biosimilars – Management […]

What: Specialty Drug Webinar on Biosimilars When: January 27, 2016 from 2 – 3 PM (EST) Click Here to REGISTER NOW  – Seats are Limited! Join RJ Health Systems for the first in a series of two webinars focusing on Biosimilars and what effect they will have on the Specialty Drug Industry. “Biosimilars – State […]